Efficacy of secukinumab in patients with hidradenitis suppurativa based on the international hidradenitis suppurativa severity scoring system (IHS4): A post hoc analysis of the SUNSHINE and SUNRISE trials

被引：0

作者：

Zouboulis, Christos C. ^{[1
,2
,3
,4
,5
,6
]}

Kyrgidis, Athanassios ^{[1
,7
]}

Alavi, Afsaneh ^{[1
,8
]}

Jemec, Gregor B. E. ^{[1
,9
]}

Martorell, Antonio ^{[1
,10
]}

Marzano, Angelo V. ^{[11
,12
]}

van der Zee, Hessel H. ^{[1
,13
]}

Muscianisi, Elisa ^{[14
]}

Kasparek, Torben ^{[15
]}

Bachhuber, Teresa ^{[16
]}

Wozniak, Magdalena B. ^{[16
]}

Ortmann, Christine-Elke ^{[15
]}

Lobach, Iryna ^{[15
]}

Ravichandran, Shoba ^{[14
]}

Tzellos, Thrasyvoulos ^{[1
,17
]}

机构：

[1] European Hidradenitis Suppurativa Fdn EHSF, Dessau, Germany

[2] Brandenburg Med Sch Theodor Fontane, Dessau, Germany

[3] Staedt Klinikum Dssau, Fac Hlth Sci Brandenburg, Dept Dermatol, Dessau, Germany

[4] Staedt Klinikum Dssau, Fac Hlth Sci Brandenburg, Dept Venereol, Dessau, Germany

[5] Staedt Klinikum Dssau, Fac Hlth Sci Brandenburg, Dept Allergol, Dessau, Germany

[6] Staedt Klinikum Dssau, Fac Hlth Sci Brandenburg, Dept Immunol, Dessau, Germany

[7] Aristotle Univ Thessaloniki, Papanikolaou Gen Hosp Thessaloniki, Dept Maxillofacial Surg, Thessaloniki, Greece

[8] Mayo Clin, Dept Dermatol, Rochester, MN USA

[9] Univ Copenhagen, Zealand Univ Hosp, Roskilde & Hlth Sci Fac, Dept Dermatol, Copenhagen, Denmark

[10] Hosp Manises, Dept Dermatol, Valencia, Spain

[11] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy

[12] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[13] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands

[14] Novartis Pharmaceut, E Hanover, NJ USA

[15] Novartis Pharma AG, Basel, Switzerland

[16] Novartis Ireland Ltd, Dublin, Ireland

[17] Nordland Hosp Trust, Dept Dermatol, Bodo, Norway

来源：

EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：27 / 28

页数：2

共 25 条

[11] Secukinumab in moderate to severe hidradenitis suppurativa: Primary endpoint analysis from the SUNSHINE and SUNRISE Phase 3 trials
Gottlieb, Alice B.
Kimball, Alexa B.
Alavi, Afsaneh
Jemec, Gregor B. E.
Wei, Xiaoling
Wozniak, Magdalena B.
Uhlmann, Lorenz
Martinez, Angela Llobet
Keefe, Deborah
Martin, Ruvie
Chen, Li
Muscianisi, Elisa
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 25 - 26
[12] The International Hidradenitis Suppurativa Severity Score System (IHS4) is a valuable tool to assess sex-associated differences
Monica Napolitano
Simona Mastroeni
Roberta Fusari
Cinzia Mazzanti
Davide Ciccone
Sabatino Pallotta
Francesca Sampogna
Luca Fania
Damiano Abeni
European Journal of Dermatology, 2020, 30 : 201 - 203
[13] Efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: Final results from the Phase 3 SUNSHINE and SUNRISE trials
Kimball, Alexa B.
Jemec, Gregor B. E.
Alavi, Afsaneh
Reguiai, Ziad
Gottlieb, Alice
Wozniak, Magdalena B.
Uhlmann, Lorenz
Martinez, Angela Llobet
Field, Claire
Ravichandran, Shoba
Muscianisi, Elisa
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB156 - AB156
[14] Secukinumab in moderate to severe hidradenitis suppurativa: Analysis of pooled data from the SUNSHINE and SUNRISE phase 3 randomized trials
Alavi, Afsaneh
Reguiai, Ziad
Jemec, Gregor B. E.
Gottlieb, Alice B.
Wozniak, Magdalena B.
Uhlmann, Lorenz
Fan, Heng
Llobet-Martinez, Angela
Ravichandran, Shoba
Kimball, Alexa B.
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 137 - 138
[15] Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials
Zouboulis, Christos C.
Passeron, Thierry
Pariser, David
Wozniak, Magdalena B.
Li, Xianjun
Uhlmann, Lorenz
Lobach, Iryna
Martinez, Angela Llobet
Ravichandran, Shoba
Alarcon, Ivette
Offidani, Annamaria
Alam, Maryam S.
Mendes-Bastos, Pedro
BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (06) : 836 - 845
[16] Impact of secukinumab on the need for rescue surgical intervention in patients with moderate to severe hidradenitis suppurativa: Post-hoc analysis of week 16 data from sunshine and sunrise trials
van der Zee, Hessel H.
Szepietowski, Jacek C.
Sayed, Christopher
Guillem, Philippe
Hamzavi, Iltefat H.
Goldberg, Stephanie
Field, Clarice
Ortmann, Christine-Elke
Lobach, Iryna
Wozniak, Magdalena B.
Llobet-Martinez, Angela
Ravichandran, Shoba
Bachhuber, Teresa
Bechara, Falk G.
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 30 - 31
[17] Efficacy of secukinumab in patients with moderate-to-severe hidradenitis suppurativa previously treated with biologic therapy: Week 16 results from the SUNSHINE and SUNRISE trials
Zouboulis, Christos C.
Passeron, Thierry
Bastos, Pedro Mendes
Pariser, David
Offidani, Annamaria
Kasparek, Torben
Wozniak, Magdalena
Li, Xianjun
Uhlmann, Lorenz
Muscianisi, Elisa
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB160 - AB160
[18] New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials
Passera, Anna
Muscianisi, Elisa
Demanse, David
Okoye, Ginette A.
Jemec, Gregor B. E.
Mayo, Tiffany
Hsiao, Jennifer
Shi, Vivian Y.
Byrd, Angel S.
Wei, Xiaoling
Uhlmann, Lorenz
Vandemeulebroecke, Marc
Ravichandran, Shoba
Porter, Martina L.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
[19] Secukinumab and concomitant antibiotic use in patients with moderate-to-severe hidradenitis suppurativa: Week 16 efficacy and safety results from the Phase 3 SUNSHINE and SUNRISE trials
Kokolakis, Georgios
Martorell, Antonio
Kerdel, Francisco
Bettoli, Vincenzo
Giamarellos-Bourboulis, Evangelos J.
Sinclair, Rodney
Kasparek, Torben
Li, Xianjun
Martinez, Angela Llobet
Uhlmann, Lorenz
Muscianisi, Elisa
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB85 - AB85
[20] Automatic International Hidradenitis Suppurativa Severity Score System (AIHS4): A novel tool to assess the severity of hidradenitis suppurativa using artificial intelligence
Montilla, Ignacio Hernandez
Medela, Alfonso
Mac Carthy, Taig
Aguilar, Andy
Tejerina, Pedro Gomez
Sueiro, Alejandro Vilas
Perez, Ana Maria Gonzalez
de la Campa, Laura Vergara
Bastante, Loreto Luna
Castro, Ruben Garcia
Roldan, Fernando Alfageme
SKIN RESEARCH AND TECHNOLOGY, 2023, 29 (06) : e13357

← 1 2 3 →